Spinal muscular atrophy (SMA) is a form of childhood neurodegenerative disease due to the lack of SMA protein in motor neurons. This Perspective article discusses the recent progress in our understanding of pathological mechanisms, past efforts in SMA therapy developments, and future directions for translational research.
